Please login to the form below

spondyloarthritis

This page shows the latest spondyloarthritis news and features for those working in and with pharma, biotech and healthcare.

Cosentyx, Entresto drive topline growth for Novartis in Q4

The IL-17 inhibitor has continued to outpace expectations, and has been stacking up indications, with the most recent filing for approval in non-radiographic axial spondyloarthritis.

Latest news

Novartis’ Cosentyx misses the mark in Humira head-to-head

These results are a blow for Novartis, especially after the resounding positive results it unveiled at the beginning of the month for Cosentyx in non-radiographic axial spondyloarthritis (nr-axSpA).
Novartis grows in Q3 thanks to stellar performance of key drugs

This could be helped with a new approval in non-radiographic axial spondyloarthritis (nr-axSpA) – Novartis reported positive phase 3 data for Consentyx in this indication earlier this month, as it
Novartis’ Cosentyx scores again in phase 3, strengthens approval claim

Scopes approval in non-radiographic axial spondyloarthritis. Novartis has unveiled more positive phase 3 data for Cosentyx, this time in patients with non-radiographic axial spondyloarthritis (nr-axSpA). .
Novartis eyes potential new indication for Cosentyx

The new data comes from the Swiss pharma’s PREVENT trial, in patients with non-radiographic axial spondyloarthritis (nr-axSpA). ... earlier in axial spondyloarthritis,” said John Tsai (pictured below), head of global drug development and chief
UCB supports social network for SpA patients

MySpondylitisTeam is launched by MyHealthTeams. UCB has partnered with MyHealthTeams to launch a new social network called MySpondylitisTeam for patients with the chronic and inflammatory arthritis spondyloarthritis (SpA). ... Eric Peacock, co-founder

More from news
Approximately 4 fully matching, plus 13 partially matching documents found.

Latest from PMHub

Lucid Group make the cut at the PMEAs 2017

Category: Supporting Patients and Professionals. DUET: Harnessing the Power of Collaboration from Concept to Completion – Improving Patient Care in Spondyloarthritis, by AbbVie, with support from Lucid Group.
Infographic: Spondyloarthritis

Overview of spondyloarthritis patient profiles and treatment pathways. Spondyloarthritis is the name for a family of arthritis causing inflammatory rheumatic diseases; including axial spondyloarthritis, psoriatic arthritis and akylosing spondylitis,
Research Partnership

Infographic: Spondyloarthritis. ... Overview of spondyloarthritis patient profiles and treatment pathways.

More from PMHub
Approximately 1 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Senior Content Editor - Biotechnology: Salary TBC

Principal Medical Writer: Varies on experience

Freelance Medical Writer - Creative Healthcare Comms - 2 month t...: Excellent Day Rate

Senior Account / Programme Manager - MedComms - Buckinghamshire: Highly Competitive Remuneration packages

Account Management: Competitive Salary Offered

Freelance Account Manager - Creative Healthcare Comms - Immediat...: Excellent Day Rate

Senior Leadership Role – Medical Communications – North West: Highly Competitive Salary, Bonus &Benefits

FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...: Highly Competitive Day Rate, Bonus &Benefits

PMHub

Add my company

Bedrock Group

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

Virtual congresses: video thrilled the cardio tsar: Chris Ross explores the key learnings from a year of virtual congresses...
When Will We Be Back To Normal?: The definitive question of 2021, whether you’re a homeschooling parent, a homebound professional, a wanderer with nowhere to go… or all three at once....
How to tell your healthcare story.: Healthcare research is not a simple story and the people in charge of those moments need to be careful about the story that they tell....